Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve
Public ClinicalTrials.gov record NCT01514162. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To further evaluate the long term clinical safety and effectiveness of the Trifecta valve
Study identification
- NCT ID
- NCT01514162
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 245 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2012
- Primary completion
- Sep 30, 2014
- Completion
- Sep 30, 2014
- Last update posted
- Feb 14, 2019
2012 – 2014
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Abbott Northwestern Hospital Cardiac Surgical Associates | Minneapolis | Minnesota | 55407 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Mission Hospital | Asheville | North Carolina | 28801 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Vanderbilt Heart Institute | Nashville | Tennessee | 37232 | — |
| Intermountain Heart & Lung Surgical Associates | Murray | Utah | 84157 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Heart Valve Diseases trials
Other public records listing Heart Valve Diseases. Sorted by last update posted; newest first. Not a recommendation.
- NCT07516444: VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial) Recruiting
- NCT07684313: TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study) Not yet recruiting
- NCT05913908: EFS of the DUO System for Tricuspid Regurgitation Recruiting
- NCT04221490: 2019-06 TRISCEND Study Active, not recruiting
- NCT06506942: The TRICURE EFS Study Recruiting
- NCT03142152: The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01514162, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 14, 2019 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01514162 live on ClinicalTrials.gov.